Page 10 - Largest South Korean (KOSPI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Mar 15, 2024

Discover large cap South Korean Pharmaceuticals & Biotech companies that are on the KOSPI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

248 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A363250

Genesystem
₩5,760.00-1.7%-21.1%₩40.2bn/aPS25.7xn/an/a

A018680

Seoul Pharma
₩3,410.00-2.3%-16.0%₩39.8bn/an/an/an/a

A036480

Daesung Microbiological Labs
₩10,300.000%3.1%₩39.1bn/aPS1.5xn/a0.7%

A318160

Cell Bio Human Tech
₩4,180.009.3%n/a₩38.7bn/aPS1.5xn/an/a

A080720

Union Korea Pharm
₩5,210.00-0.6%-10.3%₩37.6bn/aPB0.9xn/an/a

A456190

Curachem
₩21,000.000%n/a₩36.8bn/an/an/an/a

A246250

SLS BIO
₩5,260.007.3%-38.7%₩35.9bn/an/an/an/a

A086060

GeneBioTech Ltd
₩4,120.000.2%0.6%₩35.5bn/aPE9.9xn/a0%

A036180

GW VitekLTD
₩552.00-12.2%-22.5%₩34.5bn/aPB1xn/an/a

A018620

WooGene B&G
₩1,133.00-0.8%-20.2%₩32.7bn/aPB1xn/an/a

A331920

Celemics
₩3,950.00-1.1%-32.5%₩32.2bn/an/an/an/a

A950220

NeoImmuneTech
₩1,581.00-5.9%-52.5%₩31.3bn/aPB0.4xn/an/a

A043090

Exergy21
₩419.00-6.1%-71.4%₩29.2bn/aPS2.6xn/an/a

A140610

Ensol Biosciences
₩3,380.00-2.7%-74.4%₩29.1bn/an/an/an/a

A179530

ADBiotech
₩2,965.000.7%-26.2%₩27.1bn/aPE7.8xn/an/a

A215380

WOOJUNG BIO
₩1,863.00-2.4%-30.1%₩25.4bn/aPB1.2xn/an/a

A446440

Epibiotech
₩10,700.00-8.4%n/a₩24.9bn/an/an/an/a

A322970

Moogene Medi
₩2,470.00-1.2%-32.2%₩24.7bn/an/an/an/a

A233250

Median Diagnostics
₩13,450.007.6%-41.5%₩23.5bn/an/an/an/a

A283100

Novomics
₩2,800.007.9%n/a₩18.3bn/an/an/an/a

A222670

Plumbline Life Sciences
₩6,150.002.8%2.7%₩17.4bn/an/an/an/a

A244460

OLIPASS
₩490.00-24.8%-89.7%₩16.9bn/aPS3.2xn/an/a

A086460

Curable
₩4,950.009.3%-33.3%₩14.6bn/an/an/an/a

A149300

Apures
₩449.0011.4%-56.3%₩12.5bn/an/an/an/a
Page 10 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.